Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
Europe
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Benzylpenicillin Procaine
2. G Procaine, Penicillin
3. Jenacillin
4. Penicillin, Procaine
5. Procaine Penicillin
6. Procaine, Benzylpenicillin
7. Procaine, Penicillin G
1. Procaine Penicillin
2. 6130-64-9
3. Duracillin A.s.
4. Penicillin 100
5. Procaine Penicillin G Monohydrate
6. Penicillin G Procaine Hydrate
7. Penicillin G Procaine [usp]
8. Benzylpenicillin Procaine Monohydrate
9. Crysticillin A.s.
10. 17r794esyn
11. Benzoic Acid, 4-amino-, 2-(diethylamino)ethyl Ester, Mono((2s,5r,6r)-3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate), Monohydrate
12. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid Compound With 2-(diethylamino)ethyl P-aminobenzoate (1:1) Monohydrate
13. Crysticillin
14. Despacilina
15. Distaquaine
16. Ledercillin
17. Millicillin
18. Parencillin
19. Premocillin
20. Prostabillin
21. Afsillin
22. Aquacilina
23. Aquacillin
24. Aquasuspen
25. Avloprocil
26. Cilicaine
27. Duracillin
28. Kabipenin
29. Mylipen
30. Neoproc
31. Procanodia
32. Sharcillin
33. Wycillin
34. Depo-penicillin
35. Penaquacaine G
36. Ampin-penicillin
37. Abbocillin-dc
38. Flo-cillin
39. Pen-fifty
40. Pro-pen
41. Diurnal-penicillin
42. Flo-cillin Aqueous
43. Penicillin G Procaine (usp)
44. Norocillin
45. Bactracillin G
46. Novocaine Penicillin
47. 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid;hydrate
48. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2s,5r,6r)-, Compd. With2-(diethylamino)ethyl 4-aminobenzoate (1:1), Monohydrateother Ca Index Names:benzoic Acid, 4-amino-, 2-(diethylamino)ethyl Ester,mono[(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.
49. Procaine Penicillin G Hydrate
50. Procaine Benzylpenicillinate Hydrate
51. Unii-17r794esyn
52. Duracillin (tn)
53. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2s,5r,6r)-, Compd. With 2-(diethylamino)ethyl 4-aminobenzoate, Hydrate (1:1:1)
54. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2s,5r,6r)-, Compd. With 2-(diethylamino)ethyl 4-aminobenzoate, Hydrate (1:1:1)
55. Procaini Benzylpenicillinum
56. Penicillin G Compd. With 2-(diethylamino)ethyl P-aminobenzoate Hydrate
57. Procaine Penicillin [ban]
58. Schembl18076
59. Benoic Acid, 4-amino-, 2-(diethylamino)ethyl Ester, Mono((2s-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate), Monohydrate
60. Chembl1200936
61. Dtxsid40210207
62. Penicillin G Procaine [mi]
63. Hy-n7120
64. S5515
65. Penicillin G Procaine [vandf]
66. Ccg-270158
67. Penicillin G Procaine [usp-rs]
68. Procaine Benzylpenicillin [mart.]
69. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxilic Acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-)- (2s,5r,6r)-, Compd. With 2-(diethylamino)ethyl P-aminobenzoate (1:1), Monohydrate
70. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxilic Acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, Compd. With 2-(diethylamino)ethyl P-aminobenzoate (1:1), Monohydrate
71. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2s-(2alpha,5alpha,6beta))-, Compd. With 2-(diethylamino)ethyl 4-aminobenzoate (1:1) Monohydrate
72. Procaine Benzylpenicillin [who-dd]
73. Procaine Benzylpenicillin [who-ip]
74. Penicillin G Procaine [green Book]
75. Penicillin G Procaine [orange Book]
76. Cs-0099461
77. Penicillin G Procaine [usp Monograph]
78. D02461
79. Penicillin G Procaine Salt Hydrate, ~1000 U/mg
80. Procaini Benzylpenicillinum [who-ip Latin]
81. Bicillin C-r Component Penicillin G Procaine
82. Penicillin G Procaine Component Of Bicillin C-r
83. Q13026783
84. 2-(diethylamino)ethyl 4-aminobenzoate (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Hydrate
85. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2s-(2.alpha.,5.alpha.,6.beta.))-, Compd. With 2-(diethylamino)ethyl 4-aminobenzoate (1:1) Monohydrate
Molecular Weight | 588.7 g/mol |
---|---|
Molecular Formula | C29H40N4O7S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 11 |
Exact Mass | 588.26177080 g/mol |
Monoisotopic Mass | 588.26177080 g/mol |
Topological Polar Surface Area | 169 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 752 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Bicillin c-r |
Active Ingredient | penicillin g procaine; Penicillin g benzathine |
Dosage Form | Injectable |
Route | Injection |
Strength | 300,000 units/ml; 150,000 units/ml |
Market Status | Prescription |
Company | King Pharms |
2 of 2 | |
---|---|
Drug Name | Bicillin c-r |
Active Ingredient | penicillin g procaine; Penicillin g benzathine |
Dosage Form | Injectable |
Route | Injection |
Strength | 300,000 units/ml; 150,000 units/ml |
Market Status | Prescription |
Company | King Pharms |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Penicillin G Procaine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Penicillin G Procaine manufacturer or Penicillin G Procaine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Penicillin G Procaine manufacturer or Penicillin G Procaine supplier.
PharmaCompass also assists you with knowing the Penicillin G Procaine API Price utilized in the formulation of products. Penicillin G Procaine API Price is not always fixed or binding as the Penicillin G Procaine Price is obtained through a variety of data sources. The Penicillin G Procaine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Despacilina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Despacilina, including repackagers and relabelers. The FDA regulates Despacilina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Despacilina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Despacilina manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Despacilina supplier is an individual or a company that provides Despacilina active pharmaceutical ingredient (API) or Despacilina finished formulations upon request. The Despacilina suppliers may include Despacilina API manufacturers, exporters, distributors and traders.
click here to find a list of Despacilina suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Despacilina DMF (Drug Master File) is a document detailing the whole manufacturing process of Despacilina active pharmaceutical ingredient (API) in detail. Different forms of Despacilina DMFs exist exist since differing nations have different regulations, such as Despacilina USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Despacilina DMF submitted to regulatory agencies in the US is known as a USDMF. Despacilina USDMF includes data on Despacilina's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Despacilina USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Despacilina suppliers with USDMF on PharmaCompass.
A Despacilina CEP of the European Pharmacopoeia monograph is often referred to as a Despacilina Certificate of Suitability (COS). The purpose of a Despacilina CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Despacilina EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Despacilina to their clients by showing that a Despacilina CEP has been issued for it. The manufacturer submits a Despacilina CEP (COS) as part of the market authorization procedure, and it takes on the role of a Despacilina CEP holder for the record. Additionally, the data presented in the Despacilina CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Despacilina DMF.
A Despacilina CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Despacilina CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Despacilina suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Despacilina as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Despacilina API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Despacilina as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Despacilina and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Despacilina NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Despacilina suppliers with NDC on PharmaCompass.
Despacilina Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Despacilina GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Despacilina GMP manufacturer or Despacilina GMP API supplier for your needs.
A Despacilina CoA (Certificate of Analysis) is a formal document that attests to Despacilina's compliance with Despacilina specifications and serves as a tool for batch-level quality control.
Despacilina CoA mostly includes findings from lab analyses of a specific batch. For each Despacilina CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Despacilina may be tested according to a variety of international standards, such as European Pharmacopoeia (Despacilina EP), Despacilina JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Despacilina USP).